Widespread deficits in somatostatin but not neuropeptide Y concentrations in Alzheimer's disease cerebral cortex. 1993

S M Gabriel, and L M Bierer, and V Harotunian, and D P Purohit, and D P Perl, and K L Davis
Departments of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029.

Somatostatin-like immunoreactivity (SLI) and neuropeptide Y-like immunoreactivity (NPYLI) were measured in the cerebral cortex of 49 patients with Alzheimer's disease (AD), and 9 elderly controls. Concentrations of SLI were lower in AD patients relative to controls in 9 of 10 cortical regions. In contrast, no significant differences in NPYLI concentrations between the two groups were observed in any of 10 regions. These studies suggest a dissociation between SLI deficits and NPYLI concentrations in the postmortem cerebral cortex of AD patients. The apparent sparing of NPYLI-containing neurons suggests that neuropeptide Y may be located within a separate group of neurons compared to somatostatin.

UI MeSH Term Description Entries
D007106 Immune Sera Serum that contains antibodies. It is obtained from an animal that has been immunized either by ANTIGEN injection or infection with microorganisms containing the antigen. Antisera,Immune Serums,Sera, Immune,Serums, Immune
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D009478 Neuropeptide Y A 36-amino acid peptide present in many organs and in many sympathetic noradrenergic neurons. It has vasoconstrictor and natriuretic activity and regulates local blood flow, glandular secretion, and smooth muscle activity. The peptide also stimulates feeding and drinking behavior and influences secretion of pituitary hormones. Neuropeptide Y-Like Immunoreactive Peptide,Neuropeptide Tyrosine,Neuropeptide Y Like Immunoreactive Peptide,Tyrosine, Neuropeptide
D009994 Osmolar Concentration The concentration of osmotically active particles in solution expressed in terms of osmoles of solute per liter of solution. Osmolality is expressed in terms of osmoles of solute per kilogram of solvent. Ionic Strength,Osmolality,Osmolarity,Concentration, Osmolar,Concentrations, Osmolar,Ionic Strengths,Osmolalities,Osmolar Concentrations,Osmolarities,Strength, Ionic,Strengths, Ionic
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D002102 Cadaver A dead body, usually a human body. Corpse,Cadavers,Corpses
D002540 Cerebral Cortex The thin layer of GRAY MATTER on the surface of the CEREBRAL HEMISPHERES that develops from the TELENCEPHALON and folds into gyri and sulci. It reaches its highest development in humans and is responsible for intellectual faculties and higher mental functions. Allocortex,Archipallium,Cortex Cerebri,Cortical Plate,Paleocortex,Periallocortex,Allocortices,Archipalliums,Cerebral Cortices,Cortex Cerebrus,Cortex, Cerebral,Cortical Plates,Paleocortices,Periallocortices,Plate, Cortical
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

S M Gabriel, and L M Bierer, and V Harotunian, and D P Purohit, and D P Perl, and K L Davis
January 1996, Biological psychiatry,
S M Gabriel, and L M Bierer, and V Harotunian, and D P Purohit, and D P Perl, and K L Davis
September 1986, Neuroscience letters,
S M Gabriel, and L M Bierer, and V Harotunian, and D P Purohit, and D P Perl, and K L Davis
September 1986, Annals of neurology,
S M Gabriel, and L M Bierer, and V Harotunian, and D P Purohit, and D P Perl, and K L Davis
October 1986, Annals of neurology,
S M Gabriel, and L M Bierer, and V Harotunian, and D P Purohit, and D P Perl, and K L Davis
January 1988, Synapse (New York, N.Y.),
S M Gabriel, and L M Bierer, and V Harotunian, and D P Purohit, and D P Perl, and K L Davis
June 1988, Annals of neurology,
S M Gabriel, and L M Bierer, and V Harotunian, and D P Purohit, and D P Perl, and K L Davis
May 1991, Neurology,
S M Gabriel, and L M Bierer, and V Harotunian, and D P Purohit, and D P Perl, and K L Davis
January 1986, Neuroscience letters,
S M Gabriel, and L M Bierer, and V Harotunian, and D P Purohit, and D P Perl, and K L Davis
August 1987, Neuroscience letters,
S M Gabriel, and L M Bierer, and V Harotunian, and D P Purohit, and D P Perl, and K L Davis
July 1997, Cell and tissue research,
Copied contents to your clipboard!